Depyrogenated Sterile Empty Vials Market Size By Product (2 ml, 5 ml, 10 ml, 20 ml, >20 ml), By Package Technology (Glass {Molded, Tubular}, Plastic), By End-use (Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Jan 2020  |  Report ID: GMI3058  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Depyrogenated Sterile Empty Vials Market size exceeded USD 0.8 Billion in 2019 and is expected to achieve over 7.6% CAGR up to 2026. Increasing demand in various research laboratories and clinical settings will drive industry growth during the forthcoming years.
 

Depyrogenated sterile empty vials market

Get more details on this report - Request Free Sample PDF
 

Depyrogenation process can be defined as the reduction of pyrogens, including bacterial endotoxins, either by inactivation or removal. Depyrogenation is critical in preparing packaging solutions for injectable drug products. Pharmaceutical packaging components such as vials, ampoules and stoppers require specific depyrogenation procedures based on the component’s material. The commonly used depyrogenation techniques include dry heat, moist heat, rinsing and ultrafiltration.
 

Packaging of pharmaceutical products is a broad multi-faceted and encompassing task. It differs substantially from other packaging and requires the application of large amount of scientific as well as engineering expertise to deliver a product. It focuses on information and knowledge from a wide range of scientific disciplines, including chemistry, material science, physical testing and engineering, among others.
 

Focus of industry players on introduction of novel and advanced vials has led to development of various depyrogenated sterile empty vials over the recent years. Market players such as Gerresheimer, Stevanato, SGD Pharma, Thermo Fisher Scientific and others are focusing their efforts on R&D activities for development of technologically advanced depyrogenated sterile empty vial manufacturing platform. Increasing demand for depyrogenated sterile empty vials in various research laboratories and clinical settings will further drive industry growth during the forthcoming years.
 

Depyrogenated Sterile Empty Vials Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: USD 0.8 Billion
Historical Data for: 2015 to 2018 Forecast Period: 2020 - 2026
Forecast Period 2020 - 2026 CAGR: 7.6% 2026 Value Projection: USD 1.4 Billion
Pages: 250 Tables, Charts & Figures: 313
Geographies covered (17): U.S., Canada, Germany, UK, France, Italy, Spain, The Netherlands, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE
Segments covered: Product, Package Technology, End-use and Region
Companies covered (11): APG Pharma, Corning Incorporated, DWK Life Sciences, Gerresheimer, Nipro PharmaPackaging, Radpharm Scientific, SCHOTT AG, Stevanato Group, SGD Pharma, Thermo Fisher Scientific and VWR International
Growth Drivers:
  • Government policies to support innovative packaging in developing economies
  • Increasing prevalence of infectious diseases across the globe
  • Technological advancements
  • Growing usage in compounding and clinical labs
Pitfalls & Challenges:
  • Surging demand for other parenteral packaging alternatives

Request 15% Free Customization on this Report
 

The quality of the packaging of pharmaceutical products play a crucial role in maintaining product quality and efficacy

Depyrogenated Sterile Empty Vials Market Size By Product

Get more details on this report - Request Free Sample PDF
 

Increasing prevalence of infectious diseases worldwide will serve to be a major factor rendering positive impact on the market. According to UNAIDS, in 2018, around 37.9 million people across the globe were living with HIV, wherein, 1.7 million were newly infected. Rising number of people suffering from such infectious diseases will increase the demand for depyrogenated sterile empty vials for appropriate sample storage, thus, accelerating the industry growth. In addition, surge in the number of clinical labs for performing various medical and diagnostic tests will further favor the depyrogenated sterile empty vials market expansion.
 

Moreover, pharma packaging is progressively evolving in terms of security features as well as innovative designs. Government policies to encourage the development of advanced pharmaceutical packaging will serve to be another driver, accelerating the market progress. The primary, secondary and tertiary pharmaceutical packaging is undergoing self-transformation to minimize cost, reduce burden on logistic chain and improve visibility. Growing investments by several pharmaceutical and biopharmaceutical companies in R&D activities for development of innovative packaging solutions will encourage the depyrogenated sterile empty vials industry growth. However, inclination towards other parenteral packaging alternatives may restrain the market growth over the forthcoming years.
 

Usage of 20 ml depyrogenated sterile empty vials for storage of parenteral formulations will spur the market size

Depyrogenated sterile empty vials are segmented into 2 ml, 5 ml, 10 ml, 20 ml and more than 20 ml vials. 20 ml vials segment held around 14% market share in 2019 and is projected to show lucrative growth over the forecast period. Demand for clear 20 ml glass vials, pre-assembled with stopper and aluminium crimp seals, for efficient storage of parenteral formulations is on rise. Additionally, usage of 20ml vials for decanting and transportation of small amounts of solvents will escalate the demand for such vials in various clinical and research laboratories, thereby, fostering the market expansion.
 

Technologically advanced depyrogenated sterile empty glass vials offer improved chemical durability and damage resistance

Based on package technology, the depyrogenated sterile empty vials market is divided into glass and plastic vials. Glass vials market demand was valued over USD 650 million in 2019, owing to the advantages offered by glass vials over plastic including enhanced chemical durability and damage resistance. Moreover, glass vials enable pharmaceutical and biopharmaceutical companies to effectively deliver and store critical drug formulations. Increasing adoption of both molded and tubular depyrogenated sterile empty glass vials in chemical and biological reactions, plant cell culture, photobiological studies as well as sample collection and storage will accelerate market growth during the forthcoming years.
 

Patient inclination towards compounding labs to avail the benefits of personalized medicine will offer opportunities for segment growth

Compounding labs market accounted for significant revenue share in 2019 and is estimated to witness around 7.5% CAGR over the analysis period. Growing patient preference towards personalized medicine in developed economies will surge the demand for depyrogenated sterile empty vials in compounding labs. Personalised medication offered by compounding labs for corrective patient management results in improved health outcomes. Thus, growing demand for compounded medication that is not available commercially and is formulated for specific patient needs will prove beneficial for market progression.
 

U.S. depyrogenated sterile empty vials market growth is set to proceed swiftly due to increasing focus on innovative pharmaceutical packaging

North America Depyrogenated Sterile Empty Vials Market

Get more details on this report - Request Free Sample PDF
 

North America held more than 35% revenue share in 2019 and is estimated to show considerable growth over the analysis period. Rigorous investments by pharma and biotech companies in R&D activities for developing innovative packaging will primarily drive the regional market growth.
 

U.S. market is poised to exceed USD 475 million by 2026. Market growth is attributed to government funding and technological progress in the booming pharmaceutical and biologics packaging business. Moreover, increasing number of clinical labs in the U.S. will accelerate the demand for depyrogenated sterile empty vials. Strong foothold of key industry players in the U.S. will further impact the regional market growth during the forecast period.
 

Inorganic growth strategies in depyrogenated sterile empty vials industry will offer opportunities for market expansion

Some of the key players operating in the depyrogenated sterile empty vials market share are APG Pharma, Corning, DWK Life Sciences, Nipro PharmaPackaging, SCHOTT, SGD Pharma and Thermo Fisher Scientific. These key industry players implement various strategic initiatives that render competitive advantage to the companies.
 

Some of the recent industry developments:

  • In April 2019, Schott AG, entered into collaboration with SINCAD to ensure the highest quality pharmaceutical packaging. The collaboration offered SCHOTT with SINCAD’s most advanced vision control systems to inspect the dimensional accuracy, appearance, color and 3D laser profile of individual products. The strategy strengthened SCHOTT’s expertise in the field of camera inspection systems to ensure the product quality.
     
  • In March 2018, SGD Pharma introduced its Clareo range of molded glass vials for injectable solutions with more flat and uniform bottoms, that offer easy thermal transfer during freeze-drying processes. The new product launch helped the company to strengthen its existing product portfolio and broaden its customer base.
     

The depyrogenated sterile empty vials market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in units from 2015 to 2026, for the following segments:

Depyrogenated Sterile Empty Vials Market, By Product, 2015 - 2026 (USD Million, 000’ Units)

  • 2 ml
  • 5 ml
  • 10 ml
  • 20 ml
  • More than 20 ml

By Package Technology, 2015 - 2026 (USD Million)

  • Glass
    • Molded
    • Tubular
  • Plastic

By End-use, 2015 - 2026 (USD Million)

  • Clinical labs
  • Compounding labs
  • Pharmaceutical companies
  • Contract manufacturing organizations
  • Distributors
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East Asia & Africa
    • Saudi Arabia
    • South Africa
    • UAE
       

Frequently Asked Questions (FAQ) :

According to this report, the 20 ml vials segment held around 14% market share in 2019.
The U.S. depyrogenated sterile empty vials market is poised to exceed USD 475 million by 2026, says a GMI report.
Glass vials market holds the maximum market share with valuation of over USD 650 million in 2019.
The compounding labs market accounted for significant revenue share in 2019 and is estimated to witness around 7.5% CAGR over the analysis period.

Buy NowImmediate delivery available

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

GMIPulse Subscription Trial

Take a free trial of GMIPuse, our report store; designed to provide clients a range of market research services, all on a single platform.

Start Your Free Trial

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X